Steven A Seinberg insider trades: Biotime (BTIM) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Steven reports to the SEC
Open-market buys and sales
2 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Sep 3, 2010 | BTIM | ↓ Sell | 60,000 | $4.45 | $267K | Direct | Sep 3, 2010 (0d) |
| May 28, 2009 | BTIM | ↓ Sell | 22,500 | $2.54 | $57K | Direct | May 29, 2009 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Steven A Seinberg's insider trades
Steven A Seinberg is Chief Financial Officer at Biotime (BTIM). Since May 28, 2009, Steven has reported no open-market purchases and 2 sales worth $324K on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include option exercises (2 filings), grants and awards (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every BTIM insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.